09:13 AM
Alpharma (ALO) agrees to be bought by King Pharmaceuticals (KG) for $1.6B, more than three months after initially rejecting the bid as 'inadequate.' The deal is a 67% premium over Alpharma's closing price on Aug. 4. Premarket: ALO +7.2%. KG +1.5%.
Comment!
09:17 AM
King Pharmaceuticals (KG) presses on in its hostile bid for Alpharma (ALO), extending the deadline for the $37/share offer to Nov. 21 instead of Oct. 10. Alpharma rejected the bid last month as 'inadequate.' KG +5.6% pre-market.
Comment!
Thursday, September 11, 2008
09:30 AM
King Pharmaceuticals (KG) ups its bid for Alpharma (ALO) to $1.6B, or $37/share. After Alpharma's rejection of an earlier $33/share offer, King is taking the offer directly to shareholders and warns it may launch a proxy battle if the bid is rejected.
Comment!
Tuesday, September 2, 2008
11:59 AM
Alpharma (ALO) adopts a poison pill it hopes will protect it from King Pharmaceuticals' (KG) unwanted courtship.
Comment!
Monday, August 25, 2008
09:37 AM
King Pharmaceuticals (KG) reveals that Alpharma (ALO) rejected a $1.43B takeover bid earlier this month. Still optimistic about a future deal, King's bid represented a 49% premium at the time of the offer. Pre-market shares: ALO +1.1%, KG -1.6%.
Comment!
Thursday, August 21, 2008
09:56 AM
Medical insurers (AET, WLP, MHS) refuse to pay for Alpharma's (ALO) $5 pain patch - a runaway success with doctors. The equivalent pill costs just $0.38. ALO -3%.
Comment!